News

NY Gov. Hochul announces $40 million Biodefense Commercialization Fund

New York Gov. Kathy Hochul announced Thursday that her state would open up a $40 million Biodefense Commercialization Fund to support the state’s growing Life Science industry.

The fund would provide grants to companies within the state working to bring to market infectious disease solutions that would address or mitigate the spread of infectious diseases, including COVID-19 and its variants.

“No state was hit harder and faster by COVID-19 than New York State — and it is incumbent upon us to use the lessons we learned to better prepare for the future,” Hochul said. “The Biodefense Commercialization Fund will help the next generation of startups and early-stage companies combat infectious diseases while creating jobs and investment in New York’s life science industry. We want to ensure that New York is where these groundbreaking companies start and operate, and that our state is at the center of the search for solutions to the world’s most pressing problems.”

Hochul said the fund would fast track qualified startups, early stage companies and late stage academic research in New York institutions that are developing promising diagnostics, vaccines, therapeutics and other innovations to prevent, treat or mitigate infectious health threats. Companies would be eligible for grants of up to $4 million, while academic institutions would be eligible for grants up to $500,000. Preference will be given to projects with the highest potential for commercial viability.

The fund will be managed by Empire State Development, with guidance from an executive committee made up of representatives from New York State’s Department of Health, Columbia University, Icahn School of Medicine at Mount Sinai, and two venture funds. Applications will be reviewed by a panel of experts in the biopharma industry, life science venture investors and academic scientists.

Liz Carey

Recent Posts

Gates Foundation pledges up to $120M to spur access to COVID-19 drug molnupiravir for low-income countries

Recognizing the delays that have plagued low-income countries at nearly every aspect of the COVID-19…

2 days ago

House advances Secure Equipment Act

House Republican Whip Rep. Steve Scalise (R-LA) and U.S. Rep. Anna G. Eshoo (D-CA) applauded…

2 days ago

BARDA accepting applications for at-home COVID-19 diagnostics, technologies

The Biomedical Advanced Research and Development Authority (BARDA) announced a new solicitation this week for…

2 days ago

CISA awards $2M for cybersecurity workforce training

Cybersecurity and Infrastructure Security Agency (CISA) officials announced that two organizations have secured awards totaling…

2 days ago

FDA expands use of COVID-19 vaccine booster doses in eligible populations

On Wednesday, the U.S. Food and Drug Administration took action to expand the use of…

2 days ago

House approves sweeping bipartisan bill to revamp Strategic National Stockpile

The U.S. House of Representatives on Wednesday voted 397-22 to approve a bipartisan bill that…

3 days ago

This website uses cookies.